Roxanol and Light chain analysis abnormal - a phase IV clinical study of FDA data

Summary:

Light chain analysis abnormal is reported as a side effect among people who take Roxanol (morphine sulfate), especially for people who are female, 30-39 old, also take Cytoxan, and have Breast cancer.

The phase IV clinical study analyzes which people have Light chain analysis abnormal when taking Roxanol. It is created by eHealthMe based on reports of 804 people who have side effects when taking Roxanol from the FDA, and is updated regularly.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.

What is Light chain analysis abnormal?

Light chain analysis abnormal is found to be associated with 74 drugs and 50 conditions by eHealthMe. Check the latest studies of Light chain analysis abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

804 people reported to have side effects when taking Roxanol.
Among them, 13 people (1.62%) have Light chain analysis abnormal.

Could Roxanol cause Light chain analysis abnormal?

Among these 13 people:

What is the gender of people who have Light chain analysis abnormal when taking Roxanol? *

female: 100 %
male: 0.0 %

What is the age of people who have Light chain analysis abnormal when taking Roxanol? *

What are other drugs people take besides Roxanol? *

What are other side effects people have besides Light chain analysis abnormal? *

Wheezing (a high-pitched whistling sound made while you breath): 13 people, 100.00%
Fungal Infection: 13 people, 100.00%
Depression: 13 people, 100.00%
Discomfort: 13 people, 100.00%
Disease Progression: 13 people, 100.00%
Dyspnea (difficult or laboured breathing): 13 people, 100.00%
Emotional Distress: 13 people, 100.00%
Exostosis (formation of new bone on the surface of a bone): 13 people, 100.00%
Facial Pain: 13 people, 100.00%
Fatigue (feeling of tiredness): 13 people, 100.00%

What are the existing conditions these people have? *

Breast Cancer: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Roxanol and have Light chain analysis abnormal?

- Check whether Light chain analysis abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxanol:

Roxanol (807 reports)

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Light chain analysis abnormal:

Light chain analysis abnormal (74 drugs)

Browse all the conditions that are associated with Light chain analysis abnormal:

Light chain analysis abnormal (50 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Roxanol) and Roxanol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.